Companies / FluidAI Medical
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | Oct 10, 2023 | US$15M | SOSV and Graphene Ventures (co-leads); Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital. US$15M (C$20M) all-primary, mostly equity Series A announced Oct 10 2023 at HLTH (CNW); co-led by SOSV and Graphene Ventures (board seat) with Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital, Kyto Technology and Life Science, Juno Pharmaceuticals and SLS Partnering (last three not given rows) plus Ontario Together Fund grant money inside the total. Company was NERv Technology until Oct 2022 |
Data as of September 26, 2026. Suggest a correction